<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/02ECE3B0-F864-4593-BCE9-348E204E2058"><gtr:id>02ECE3B0-F864-4593-BCE9-348E204E2058</gtr:id><gtr:name>MRC National Inst for Medical Research</gtr:name><gtr:address><gtr:line1>The Ridgeway</gtr:line1><gtr:line2>Mill Hill</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>NW7 1AA</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/02ECE3B0-F864-4593-BCE9-348E204E2058"><gtr:id>02ECE3B0-F864-4593-BCE9-348E204E2058</gtr:id><gtr:name>MRC National Inst for Medical Research</gtr:name><gtr:address><gtr:line1>The Ridgeway</gtr:line1><gtr:line2>Mill Hill</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>NW7 1AA</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/446AD0B8-61F0-43D2-B32E-BB9A8AD1D66D"><gtr:id>446AD0B8-61F0-43D2-B32E-BB9A8AD1D66D</gtr:id><gtr:firstName>David</gtr:firstName><gtr:surname>Ogden</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_U117584254"><gtr:id>724EB7B4-5F8D-4494-B3B3-8E299E0EF8E3</gtr:id><gtr:title>Ion channels in synaptic transmission</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_U117584254</gtr:grantReference><gtr:abstractText>Synaptic transmission is the primary signalling process between neurons in the brain, underlying most brain functions and implicated in most brain pathologies. Thus it is important to understand the fine details of the mechanisms involved, particularly the function of neurotransmitter activated ion channels in situ. It is also the primary target of centrally acting medicines and the methodology developed is aimed specifically at improving the detection of potential centrally acting drugs. ||Viral ion channels are potential drug targets in viral infection.</gtr:abstractText><gtr:technicalSummary>Aims|1) To study the role of ion channels in neuronal excitability, particularly the interaction between fast synaptic channels and slow changes in excitability due to metabotropic receptor activation.|2) To develop methods for photolysis applied in neuroscience and in drug discovery.|3) The role of ion channels of viral origin in infection.||Methodology|Photolytic release of neurotransmitters from caged precursors is used with conventional patch clamp recording and fast fluorescence imaging to investigate the excitability changes in Purkinje neurones of the cerebellum and CA1 neurones of the hippocampus. Methods to localise the photolysis to particular areas of single neurones and to a synaptic spatial scale are being developed.||Ion channels of influenza virus are studied after transfection and expression in a mammalian cell line.||Scientific advances|1) Two signalling pathways underlying excitability in Purkinje neurones have been separated and the mechanisms elucidated.|2) Methods are being developed for photolytic release of transmitters to activate receptors on a physiological timescale in high throughput screening for drugs that modify receptor function.</gtr:technicalSummary><gtr:fund><gtr:end>2008-12-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>1999-08-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>1280742</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications/><gtr:identifiers><gtr:identifier type="RCUK">MC_U117584254</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>